Trial Profile
A Phase 1 trial of LAM-003
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Feb 2019
Price :
$35
*
At a glance
- Drugs LAM 003 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 05 Apr 2017 New trial record